27.05.2024
To the attention of interested persons
The Commission Implementation Decision of 24.05.2024 concerning, within the framework of Article 31 of Directive 2001/83/EC of the European Parliament and of the Council, the marketing authorisations granted for medicinal products for human use which have been authorised or are in the process of being authorised, based on the clinical studies conducted at Synapse Labs Pvt. Ltd, and Annex I to the Commission Implementation Decision of 24.05.2024 – the List of medicinal products authorised through national procedure and of applications for marketing authorisation
download decision …
download annex …